These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Autoimmune progesterone dermatitis in the adolescent population. Aghazadeh N; Chattha AJ; Hartz MF; Davis DMR Pediatr Dermatol; 2021 Mar; 38(2):380-384. PubMed ID: 33368681 [TBL] [Abstract][Full Text] [Related]
8. Progestogen Hypersensitivity: Heterogeneous Manifestations with a Common Trigger. Buchheit KM; Bernstein JA J Allergy Clin Immunol Pract; 2017; 5(3):566-574. PubMed ID: 28483311 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune progesterone dermatitis: Update and insights. Nguyen T; Razzaque Ahmed A Autoimmun Rev; 2016 Feb; 15(2):191-7. PubMed ID: 26554933 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of exogenous progestogen hypersensitivity. Jo EJ; Lee SE; Park HK Asian Pac J Allergy Immunol; 2019 Sep; 37(3):183-187. PubMed ID: 30118245 [TBL] [Abstract][Full Text] [Related]
11. A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis. Bernstein IL; Bernstein DI; Lummus ZL; Bernstein JA J Womens Health (Larchmt); 2011 Apr; 20(4):643-8. PubMed ID: 21417747 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune progesterone dermatitis: a retrospective case series. Aghazadeh N; Berry NA; Torgerson RR; Park MA; Davis DMR Int J Womens Dermatol; 2022 Oct; 8(3):e009. PubMed ID: 35822192 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Snyder JL; Krishnaswamy G Ann Allergy Asthma Immunol; 2003 May; 90(5):469-77; quiz 477, 571. PubMed ID: 12775127 [TBL] [Abstract][Full Text] [Related]
14. A focused report on progestogen hypersensitivity. Patel DH; Fine LM; Bernstein JA Expert Rev Clin Immunol; 2023 Apr; 19(4):357-363. PubMed ID: 36800518 [TBL] [Abstract][Full Text] [Related]
15. Dermatological Manifestations in Patients Undergoing In Vitro Fertilisation: A Prospective Study. Sood A; Sahu S; Karunakaran S; Joshi RK; Raman DK J Cutan Med Surg; 2018; 22(3):280-284. PubMed ID: 29332425 [TBL] [Abstract][Full Text] [Related]
16. The role of intradermal skin testing and patch testing in the diagnosis of autoimmune progesterone dermatitis. Stranahan D; Rausch D; Deng A; Gaspari A Dermatitis; 2006 Mar; 17(1):39-42. PubMed ID: 16800278 [TBL] [Abstract][Full Text] [Related]
17. Progesterone autoimmune dermatitis with positive autologous serum skin test result. García-Ortega P; Scorza E Obstet Gynecol; 2011 Feb; 117(2 Pt 2):495-498. PubMed ID: 21252802 [TBL] [Abstract][Full Text] [Related]
18. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques. Nadarajah R; Rajesh H; Wong KY; Faisal F; Yu SL Singapore Med J; 2017 Jun; 58(6):294-297. PubMed ID: 27090598 [TBL] [Abstract][Full Text] [Related]
19. Whole course of treatment of autoimmune progesterone dermatitis that had spontaneously resolved during pregnancy: A case report and review of the literature. Huang Y; Ye S; Bao X; Yang R; Huang J Front Immunol; 2022; 13():939083. PubMed ID: 36159858 [TBL] [Abstract][Full Text] [Related]
20. Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report. Varghese A; Paul T; Kim H; Van Uum S; Vadas P; Azzola A Allergy Asthma Clin Immunol; 2021 Jun; 17(1):58. PubMed ID: 34120629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]